Analyst Ratings for Eleven Biotherapeutics (EBIO)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/10/2018 | Laidlaw | N/A | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.83 (3.29) |
16.25% | Details |
3/20/2018 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
2.00 (N/A) |
1.05 (3.29) |
213.33% | Details |